Latest Fundamental News
RBNZ Holds OCR at 2.75% in 4-3 Vote, Defying Hike Bets as NZD Falls
Peppermint Lifts Q1 Receipts 15x as P2M Payments Scale Up
USD/JPY Nears 158 as Fed, BoJ and Israeli Vote Converge This Week
AUD/NZD Hits 13-Year High as RBNZ Holds and Aussie CPI Runs Hot
RMA Global Settles Its Curated Social Earn-Out Below the US$1.5M Cap
Dexus Office Occupancy Slips to 94.2% From 95.7% Last Quarter
betr Posts Q1 FY27 Turnover Up 19.1% as October Margin Rebounds So Far
Fundamental Analysis
Why the US Dollar Outlook Is Less One-Way Despite Hot Inflation
Why the Koruna Risk Premium Won’t Jump on Prague’s Media Fight
What Is Really Driving Rupee Pressure Beyond the Oil Headlines
Australia’s K-Shaped Consumer: Which Retailers Sit on the Weak Arm?
Why the Baht Is Sliding Despite Foreign Inflows: Thai Outlook
South Korea’s GDP Beat Rests on Chips While Consumers Retreat
GBP/USD Forecast: Why Sterling Is Soft Ahead of the Budget
EUR/USD Forecast: French Bond Stress Tests the Euro Before Fed, ECB
USD/CAD Forecast: Why 1.40 Is Holding Before the BoC and Fed
Fundamental Guides & Education
Why Great AI Infrastructure Stocks Can Still Be Poor Investments
Why Great Companies Can Still Be Poor Investments at the Wrong Price
Firmus, GMO and Sharesight: How to Filter Market Headlines
Why a Range Bound Market Can Hit Records and Still Say Little
Why Scams Are Forcing the Online Classifieds Model to Change
How to Value Space Stocks: a Screen That Rules Out the Losers
What Insider Buying on the ASX Really Tells You About a Bottom
Why GLP-1 Compounding Ended in Australia and the US
Why Dividend Growth Stocks Have Beaten High Yielders on the ASX
Discover More in the Technical Analysis Hub
Go to HubFeatured ASX Fundamental Analysis Announcements
Latest ASX Fundamental Analysis Videos
Equity Valuation: Stock Analysis Methods, Metrics and Investment Decision Frameworks
Sound equity valuation underpins all forms of active investing, providing the framework to assess whether a stock is overvalued, fairly valued, or undervalued relative to its fundamental prospects. The most commonly applied valuation approaches include discounted cash flow analysis, enterprise value multiples, dividend discount models, and sum-of-parts for diversified businesses. Each methodology has strengths and limitations, and skilled investors triangulate across multiple approaches rather than relying on a single metric. Sector-specific valuation conventions matter: biotech companies are valued on risk-adjusted pipeline NPV, REITs on funds from operations and cap rates, and banks on price-to-book and return on equity. StockWire X covers equity valuation commentary from analyst upgrades and downgrades, provides earnings analysis that drives valuation model updates, and tracks the macro factors, interest rates, risk premium, and earnings growth expectations, that shift entire market valuation frameworks.
Frequently Asked Questions
What are the main equity valuation methods used by professional investors?
Professional investors use multiple equity valuation methods in parallel. Discounted cash flow analysis estimates intrinsic value based on projected future cash flows. Comparable company analysis values a stock relative to peer group multiples. Precedent transaction analysis uses M&A deal multiples as benchmarks. Sum-of-parts analysis is used for diversified businesses where different divisions have different value drivers.
What is an equity valuation example for a simple company?
A simple equity valuation example involves estimating a company's annual free cash flow, projecting growth over a forecast period, applying a terminal growth rate, and discounting back to present value using a risk-adjusted discount rate. The result is compared to the current market capitalisation to assess whether the stock is overvalued, fairly valued, or undervalued relative to the DCF-implied intrinsic value.
What is discounted cash flow analysis and when is it most useful for equity valuation?
Discounted cash flow analysis values a company by projecting future free cash flows and discounting them back to present value using a rate that reflects the risk of those cash flows. It is most useful when a company has stable, predictable cash flows and when the analyst has reasonable confidence in multi-year projections. DCF is less reliable for early-stage companies, highly cyclical businesses, or companies undergoing significant business model transitions.
How do relative valuation multiples work and what are their limitations?
Equity valuation methods vary significantly by sector. Banks are typically valued on price-to-book and return on equity. REITs are valued on funds from operations and cap rates. Biotech pre-revenue companies are valued on risk-adjusted NPV of pipeline assets. High-growth technology companies are valued on EV/revenue multiples. Using the wrong valuation methodology for a given sector produces misleading conclusions.